Trials / Completed
CompletedNCT06517602
Effect of Moringa Oleifera Leaves on Glycemic Control of Women With Type 2 Diabetes
Effect of Daily Consumption of Moringa Oleifera Leaves on Glycemic Control of Saharawi Women With Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- University of Milan · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this clinical trial was to understand whether supplementation of Moringa oleifera leaf powder improved glycemic management in Sahrawi women with type 2 diabetes living in refugee camps. The main question sought to be answered was: \- Does daily supplementation of Moringa oleifera leaf powder, in addition to oral hypoglycemic therapy, improve glycosylated hemoglobin and fasting blood glucose? Researchers compared Moringa supplementation with no Moringa consumption to see if Moringa oleifera worked to improve glycemic control. Participants had to: * Take Moringa oleifera leaves daily or abstain from consuming Moringa for 3 months. * Consistently take prescribed oral hypoglycemic agents * Undergo clinical examinations and measurement of biochemical, metabolic and body composition parameters at the time of recruitment and at the end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Supplementation of Moringa oleifera leaf powder | Women in the experimental group were asked to consistently take the prescribed oral hypoglycemic therapy and to maintain their lifestyle and eating habits. In addition, for the duration of the study (3 months), the experimental group was provided with 10 g of Moringa oleifera leaf powder daily to be consumed with main meals. |
Timeline
- Start date
- 2019-11-07
- Primary completion
- 2020-02-23
- Completion
- 2020-02-23
- First posted
- 2024-07-24
- Last updated
- 2024-07-24
Locations
1 site across 1 country: Algeria
Source: ClinicalTrials.gov record NCT06517602. Inclusion in this directory is not an endorsement.